8 results
·
18ms
·
Sources: EU EUDAMED, US FDA
BIFURCATED Y-EXTENSION
FDA 510(k)
FDA Class 2
·Neurology
GAUZE SPONGE
FDA 510(k)
FDA Class 1
·General, Plastic Surgery
Apollo Balloon Dilatation Catheter
FDA 510(k)
FDA Class 2
·Cardiovascular
SPRINT QUATTRO SECURE
FDA Adverse Event
Injury
·MEDTRONIC PUERTO RICO OPERATIONS CO·Product code NVY·February 9, 2013
PULSAR MAX
FDA Adverse Event
Injury
·GUIDANT CLONMEL IRELAND·Product code NVZ·January 10, 2011
G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code MDS·July 23, 2014
THERMA CARE
FDA Adverse Event
Injury
·PROCTER & GAMBLE PAPER PRODUCT CO·Product code IMD·March 6, 2002
Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017